SCHEMBL4894413

SCHEMBL4894413

CCN(c1ccc(OCc2ccc(C(F)(F)F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
HDAC8 Q9BY41 2/20 0.48
NPSR1 Q6W5P4 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MAOB P27338 3/20 0.43
PSEN1 P49768 2/20 0.43
PSEN2 P49810 2/20 0.43
APH1B Q8WW43 2/20 0.43
NCSTN Q92542 2/20 0.43
APH1A Q96BI3 2/20 0.43
PSENEN Q9NZ42 2/20 0.43
RORC P51449 2/20 0.43
POLB P06746 1/20 0.42
ADAMTS4 O75173 1/20 0.41
MMP13 P45452 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897727 0.91 MMP2 (0.48) MMP2MMP9HDAC8HDAC3HDAC11
SCHEMBL4899758 0.90 MMP2 (0.49) MMP2MMP9HDAC8NPSR1HDAC3
SCHEMBL4904039 0.90 KEAP1 (0.47) MMP2MMP9MAOBMMP13KEAP1
SCHEMBL4906417 0.90 HDAC8 (0.52) MMP2MMP9HDAC8NPSR1HDAC3
SCHEMBL4895643 0.88 HDAC8 (0.53) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4904391 0.87 MMP2 (0.49) MMP2MMP9HDAC8NPSR1HDAC3
SCHEMBL4911874 0.87 MAOA (0.43) MMP2MMP9MAOBMMP13KEAP1
SCHEMBL4908025 0.86 MMP9 (0.42) MMP2MMP9HDAC8NPSR1MAOB
SCHEMBL4905308 0.83 MMP2 (0.49) MMP2MMP9HDAC8NPSR1HDAC3
SCHEMBL4905352 0.82 NPSR1 (0.41) HDAC8NPSR1HDAC3HDAC11HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MMP2 4348/4885MMP9 4666/4885HDAC8 959/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MMP2 4105/4885MMP9 4632/4885HDAC8 882/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MMP2 4105/4885MMP9 4632/4885HDAC8 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.